(Editors' Note: Stellar Biotechnologies trades on the TSX Venture Exchange, symbol KLH.V, with average daily volume of C$350,000.)
Stellar Biotechnologies (OTCQB:SBOTF) (KLH.V) is the world leader in sustainable manufacturing of Keyhole Limpet Hemocyanin (KLH). Although KLH has been known as an important immune-stimulating protein (a substance that naturally induces an immune response) for over 40 years, its role as an ideal carrier molecule for vaccine antigens (substances that promote the generation of antibody and cell-mediated immune responses) against cancers and infectious agents is the basis for the fastest growing new class of drugs known as active immunotherapies.
KLH is currently involved in a mind-bending 20 active human clinical trials where many of the world's finest drug...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|